AI-generated draft from CMS source. Review and verify clinical accuracy before use.
CLINICAL STAGE / CARE PATHWAY
Patient is currently in the therapeutic intervention phase of care following persistent cervical or thoracic spinal pain that is clinically consistent with facet joint pathology after insufficient response to conservative treatments. The clinical presentation supports progression to neurolytic destruction of the facet joint nerves for symptom relief.
– Sequencing logic:
Typically, diagnostic or therapeutic facet joint injections with image guidance precede neurolytic destruction. Positive response to diagnostic blocks supports proceeding to neurolytic procedures at targeted levels.
ICD-10 / DIAGNOSIS SUPPORT
Diagnosis support includes spondylosis or other degenerative or dorsopathy diagnoses affecting the cervical or thoracic spine consistent with facet joint pain pathology and medical necessity for neurolytic intervention.
The documented diagnosis correlates with the clinical exam, imaging findings, and prior treatment history.
– Example ICD-10 options:
M47.812 – Spondylosis without myelopathy or radiculopathy, cervical region
M47.813 – Spondylosis without myelopathy or radiculopathy, cervicothoracic region
M53.82 – Other specified dorsopathies, cervical region
SUBJECTIVE / HPI SUPPORT
Patient reports chronic cervical or thoracic axial spinal pain described as persistent, moderate to severe, with limitations in neck or upper back movement, impaired activities of daily living, decreased sleep quality, and limited work tolerance despite prior conservative care efforts over an extended duration.
– Edit if needed:
neck pain
thoracic pain
greater than 6 weeks
greater than 3 months
CONSERVATIVE CARE / PRIOR TREATMENT
Patient has undergone conservative management including physician-directed physical therapy, home exercise programs, activity modification, analgesic medication trials, and at least one series of diagnostic or therapeutic facet joint injections with image guidance without sustained adequate symptom relief.
– Common conservative care examples:
Formal physical therapy
NSAID therapy
Medication management
Diagnostic facet joint injections
OBJECTIVE / DIAGNOSTIC SUPPORT
Physical examination reveals localized tenderness and reproducible pain with facet joint loading maneuvers consistent with facet-mediated pain generator.
Diagnostic imaging including spinal radiographs or MRI supports evidence of degenerative facet joint changes without alternative pain sources.
Prior diagnostic facet injections under fluoroscopy or CT guidance provided meaningful temporary pain relief, confirming the treatment target.
ASSESSMENT
Assessment: Persistent cervical/thoracic facet joint-mediated spinal pain refractory to conservative therapy. Clinical evaluation, imaging, and prior diagnostic injections support medical necessity for neurolytic destruction of the targeted facet joint nerves with image guidance to provide therapeutic benefit.
PLAN / NEXT STEP
Plan: Proceed with destruction by neurolytic agent of the cervical or thoracic paravertebral facet joint nerve(s) at the clinically indicated single facet joint level under fluoroscopic or CT image guidance. Risks, benefits, and alternative treatments discussed. Bilateral intervention will be noted if performed.
– Edit if needed:
right-sided
left-sided
bilateral
cervical levels
thoracic levels
PROCEDURE-SPECIFIC CLINICAL REQUIREMENTS
Procedure will use neurolytic agents under image guidance (fluoroscopy or CT). Ultrasound guidance and non-thermal denervation methods are not indicated for this procedure code.
Documentation supports use of a single facet joint nerve destruction as appropriate per AMA CPT definitions, acknowledging that one code represents both nerves innervating the joint.
Moderate or deep sedation, general anesthesia, or MAC are not routinely considered medically necessary unless clinically justified for this procedure.
Prior diagnostic or therapeutic injections must substantiate the clinical target and support progression to neurolytic intervention.
FOLLOW-UP / RESPONSE DOCUMENTATION
Post-procedure follow-up should document the degree of pain relief, duration of symptom improvement, functional gains, and any adverse effects.
Patient reports meaningful reduction in cervical or thoracic pain intensity, improved neck mobility, enhanced ability to perform activities of daily living, and improved sleep compared to baseline measures.
– Edit if needed:
greater than 50% pain relief
sustained relief over several months
MISSING DOCUMENTATION CHECK
– Documentation items to confirm before authorization or scheduling:
Symptom duration
Functional limitation and impact on ADLs
Details of prior conservative care and response
Medication trials
Imaging correlation to facet pathology
Diagnostic facet injection response
Plan specifying levels and laterality
Pre- and post-procedure pain assessment
Clinical rationale for neurolytic destruction
APPEAL / PEER-TO-PEER CLINICAL SUPPORT
The requested neurolytic destruction of the cervical or thoracic facet joint nerve is clinically supported by the documented diagnosis of facet-mediated pain, persistent functional impairment, refractory status to prior conservative and diagnostic interventions, and objective findings consistent with the targeted facet joint as the pain generator.
The medical record demonstrates that this therapeutic procedure is advisable based on patient history, exam, imaging, and prior diagnostic block responses to improve patient outcomes and quality of life.
COVERED PROCEDURES AND SERVICES
Facet joint interventions for pain management limited to cervical/thoracic and lumbar/sacral facet joint injections and neurolytic denervation procedures. Procedures include diagnostic and therapeutic facet joint injections (CPT codes 64490-64495) and neurolytic destruction by radiofrequency (CPT codes 64633-64636). Ultrasound guidance and non-thermal denervation techniques are not covered; only fluoroscopy or CT image guidance is accepted. Placement of posterior intrafacet implants (CPT codes 0219T-0222T) is addressed separately and not included in this article.
POLICY AND CODING REFERENCES
Local Coverage Determination (LCD) L38841, Medicare National Correct Coding Initiative (NCCI) edits, and AMA CPT Manual guidance apply. Article A58477 version 22 directs claim preparation and coding compliance. Providers must follow NCCI and OPPS packaging edits and verify valid ICD-10 diagnoses. Only facet joint injections or denervations supported by imaging guidance and medically necessary documentation are reimbursed by Medicare.
DIAGNOSIS AND MEDICAL NECESSITY
Covered ICD-10 codes include spondylosis (M47.xxx), ankylosing hyperostosis (M48.xxx), and other specified dorsopathies (M53.xxx) limited to cervical, thoracic, lumbar, and sacral regions without specification of myelopathy or radiculopathy as per coding tables. Medical necessity requires documentation of diagnostic workup, prior conservative therapy, and clinical rationale for facet intervention. Therapeutic injections require evidence that patient is not a candidate for radiofrequency ablation (RFA).
FREQUENCY AND LEVEL RESTRICTIONS
One to two levels per session per spine region (cervical/thoracic or lumbar/sacral) allowed for facet joint injections. Bilateral interventions count as a single unit with modifier -50 appended. For multiple levels, codes for additional levels (64491, 64492, 64494, 64495) must be appended sequentially and cannot be billed more than once per day. For neurolytic destruction (64633-64636), single and additional facet joints are coded separately, one unit per joint treated, with bilateral procedures requiring modifier -50.
MODIFIER GUIDANCE
Apply modifier -50 for all bilateral procedures in physician billing. Ambulatory Surgery Centers (ASC) report procedures unilaterally with RT and LT modifiers on separate lines; providers continue use of modifier -50. The KX modifier must be appended to diagnostic injection claims to indicate medical necessity per policy; misuse may prompt focused medical review.
BILLING AND CODING CAUTIONS
Claims submitted without valid and supported ICD-10 diagnosis codes will be denied as incomplete claims per Section 1833(e). Non-thermal facet joint denervations must not be reported with CPT codes 64633-64636; incorrect use may result in claim denial. Use CPT code 64999 for non-thermal denervation is non-covered and leads to denial. Use of biological substances not designated for facet joints will lead to claim denial under Benefit Policy Manual Chapter 16.
ANESTHESIA AND SEDATION
Moderate or deep sedation, general anesthesia, and monitored anesthesia care (MAC) during facet injections are considered not medically necessary and are non-covered. Exception granted only for RFA and facet cyst aspiration/rupture with documented medical necessity; frequent billing with sedation may trigger focused medical review.
DOCUMENTATION REQUIREMENTS
Medical records must fully support medical necessity and include the ordering provider’s assessment, relevant clinical history, test/procedure results, signed and dated office or operative reports. Provider signatures are mandatory on all service documentation. Documentation must justify why alternative treatments are unsuitable and confirm symptom correlation with diagnosis.
REPEAT PROCEDURES
Additional diagnostic injections beyond initial two require continued documentation of positive patient response and medical necessity with KX modifier appended. Repeat thermal neurolytic procedures must adhere to frequency restrictions defined in LCD and policy. Billing multiple procedures at the same level or using codes for nerves rather than joints violates coding rules.
PROVIDER QUALIFICATIONS
Not clearly stated in source; assume procedures require appropriately credentialed pain management specialists or practitioners authorized under Medicare guidelines per LCD and AMA CPT Manual.
SUMMARY
Facet joint syringeable injections and neurolytic ablations require image-guidance with fluoroscopy or CT, valid diagnosis from specified ICD-10 dorsopathies, modifier use reflecting laterality, and thorough documentation of medical necessity and prior conservative treatment. Non-covered codes include ultrasound-guided injections, non-thermal denervation, biologic injections, and inappropriate anesthesia use. Claims missing proper coding, documentation, or using disallowed techniques will result in denials or medical review.